Pierre Fabre S.a.

M Antoine Stenger

Henri Cousse

Gilbert Mouzin

The invention relates to new chemical compounds which can be used as drugs, as well as pharmaceutical compositions. The new products have the general formula: ##STR1## Drugs containing these active principles can be administered orally, rectally, parenterally or locally and are intended in particular for use as psychotropics, either alone or associated with other active principles. 5-Bromo-ortho-cresotamide may also be named 5-Bromo-2-hydroxy-3-methyl-benzamide.

Medicaments having psychotropic properties

5-Bromo-ortho-cresotamide and N--C.sub.1 to C.sub.4 --alkyl-5-bromo-ortho-cresotamides are useful for the potentiation of aspirin. 5-Bromo-ortho-cresotamide may also be named 5-Bromo-2-hydroxy-3-methyl-benzamide.

N--C.sub.1 to C.sub.4 -alkyl-5-bromo-ortho-cresotamides; their use as anticonvulsants. 5-Bromo-ortho-cresotamide may also be named 5-Bromo-2-hydroxy-3-methyl-benzamide.

Growing community of inventors

Castres, France

M Antoine Stenger